Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24583797)

1.

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Chen J, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ai W, Ponzoni M, Ferreri AJ, Farnen JP, Møller MB, Bueso-Ramos CE, Miranda RN, Winter JN, Piris MA, Medeiros LJ, Young KH.

Clin Cancer Res. 2014 May 1;20(9):2338-49. doi: 10.1158/1078-0432.CCR-13-3157. Epub 2014 Feb 28. Erratum in: Clin Cancer Res. 2014 Sep 15;20(18):4974. Dybaer, Karen [corrected to Dybkaer, Karen].

2.

Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.

Kato H, Karube K, Yamamoto K, Takizawa J, Tsuzuki S, Yatabe Y, Kanda T, Katayama M, Ozawa Y, Ishitsuka K, Okamoto M, Kinoshita T, Ohshima K, Nakamura S, Morishima Y, Seto M.

Cancer Sci. 2014 May;105(5):537-44. doi: 10.1111/cas.12389. Epub 2014 Apr 9.

PMID:
24581222
3.

Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.

Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.

Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.

PMID:
23726928
4.

Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.

Sato A, Nakamura N, Kojima M, Ohmachi K, Carreras J, Kikuti YY, Numata H, Ohgiya D, Tazume K, Amaki J, Moriuchi M, Miyamoto M, Aoyama Y, Kawai H, Ichiki A, Hara R, Kawada H, Ogawa Y, Ando K.

Cancer Sci. 2014 Sep;105(9):1170-5. doi: 10.1111/cas.12467. Epub 2014 Sep 8.

PMID:
24974976
5.

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma - is it necessary?

Ok CY, Ye Q, Li L, Manyam GC, Deng L, Goswami RR, Wang X, Montes-Moreno S, Visco C, Tzankov A, Dybkaer K, Zhang L, Abramson J, Sohani AR, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhang S, Parsons BM, Xu M, Møller MB, Winter JN, Piris MA, Xu-Monette ZY, Medeiros LJ, Young KH.

Oncotarget. 2015 Jun 10;6(16):13935-13946.

6.

CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.

Slack GW, Steidl C, Sehn LH, Gascoyne RD.

Br J Haematol. 2014 Dec;167(5):608-17. doi: 10.1111/bjh.13085. Epub 2014 Aug 19.

PMID:
25135752
7.

Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.

Ahn JS, Yang DH, Duk Choi Y, Jung SH, Yhim HY, Kwak JY, Sung Park H, Shin MG, Kim YK, Kim HJ, Lee JJ.

Am J Hematol. 2013 Sep;88(9):774-9. doi: 10.1002/ajh.23507. Epub 2013 Jul 23.

PMID:
23760676
8.

Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.

Adam P, Bonzheim I, Fend F, Quintanilla-Martínez L.

Adv Anat Pathol. 2011 Sep;18(5):349-55. doi: 10.1097/PAP.0b013e318229bf08. Review.

PMID:
21841405
9.

[Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].

Xu FP, Liu YH, Zhuang HG, Luo DL, Li L, Zhang F, Luo XL, Du X, Li WY, Chen Q.

Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):616-21. Chinese.

PMID:
22177246
10.

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Miranda RN, Medeiros LJ, Young KH.

Oncotarget. 2015 Mar 20;6(8):5615-33. Erratum in: Oncotarget. 2015 Jun 10;6(16):14720.

11.

Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.

Cohen M, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA.

Int J Cancer. 2014 Dec 15;135(12):2816-24. doi: 10.1002/ijc.28942. Epub 2014 May 27.

PMID:
24789501
12.

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Hu S, Xu-Monette ZY, Balasubramanyam A, Manyam GC, Visco C, Tzankov A, Liu WM, Miranda RN, Zhang L, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Han van Krieken J, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhao X, Winter JN, Zhang M, Li L, Møller MB, Piris MA, Li Y, Go RS, Wu L, Medeiros LJ, Young KH.

Blood. 2013 Apr 4;121(14):2715-24. doi: 10.1182/blood-2012-10-461848. Epub 2013 Jan 23.

13.

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.

Acta Oncol. 2014 May;53(5):669-79. doi: 10.3109/0284186X.2013.844853. Epub 2013 Oct 28.

PMID:
24164103
14.

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.

Ok CY, Xu-Monette ZY, Li L, Manyam GC, Montes-Moreno S, Tzankov A, Visco C, Dybkær K, Routbort MJ, Zhang L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Parsons BM, Rao H, Møller MB, Winter JN, Piris MA, Wang SA, Medeiros LJ, Young KH.

Mod Pathol. 2015 Jun 26. doi: 10.1038/modpathol.2015.76. [Epub ahead of print]

PMID:
26111978
15.

In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.

Stuhlmann-Laeisz C, Borchert A, Quintanilla-Martinez L, Hoeller S, Tzankov A, Oschlies I, Kreuz M, Trappe R, Klapper W.

Leuk Lymphoma. 2015 Apr 22:1-22. [Epub ahead of print]

PMID:
25899404
16.

Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.

Ziarkiewicz M, Wołosz D, Dzieciątkowski T, Wilczek E, Dwilewicz-Trojaczek J, Jędrzejczak WW, Gierej B, Ziarkiewicz-Wróblewska B.

Arch Immunol Ther Exp (Warsz). 2015 Jun 18. [Epub ahead of print]

PMID:
26084760
17.

Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.

Chang ST, Lu YH, Lu CL, Weng SF, Lin SH, Kuo SY, Chuang YT, Takeuchi K, Ohshima K, Chuang SS.

J Clin Pathol. 2014 Apr;67(4):326-32. doi: 10.1136/jclinpath-2013-201905. Epub 2013 Nov 11.

PMID:
24218026
18.

The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.

Uner A, Akyurek N, Saglam A, Abdullazade S, Uzum N, Onder S, Barista I, Benekli M.

APMIS. 2011 Apr;119(4-5):309-16. doi: 10.1111/j.1600-0463.2011.02736.x. Epub 2011 Mar 22.

PMID:
21492232
19.

Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.

Stuhlmann-Laeisz C, Szczepanowski M, Borchert A, Brüggemann M, Klapper W.

Virchows Arch. 2015 Jan;466(1):85-92. doi: 10.1007/s00428-014-1661-z. Epub 2014 Oct 23.

PMID:
25339301
20.

EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?

Hong JY, Yoon DH, Suh C, Huh J, Do IG, Sohn I, Jo J, Jung SH, Hong ME, Yoon H, Ko YH, Kim SJ, Kim WS.

Ann Oncol. 2015 Mar;26(3):548-55. doi: 10.1093/annonc/mdu556. Epub 2014 Dec 4.

PMID:
25475080
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk